ANI PHARMACEUTICALS INC - Common Stock (ANIP)
CUSIP: 00182C103
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 22,278,088
- Total 13F shares
- 6,258,413
- Share change
- -146,489
- Total reported value
- $481,254,141
- Price per share
- $76.90
- Number of holders
- 129
- Value change
- -$11,206,513
- Number of buys
- 63
- Number of sells
- 50
Quarterly Holders Quick Answers
What is CUSIP 00182C103?
CUSIP 00182C103 identifies ANIP - ANI PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 00182C103:
Top shareholders of ANIP - ANI PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
|
Company |
11%
|
2,517,424
|
$230,596,038 | $0 | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.9%
|
1,305,068
|
$103,022,068 | — | 31 Dec 2025 | |
| MERIDIAN VENTURE PARTNERS II LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,819,259
|
$102,678,978 | — | 16 Aug 2023 | |
| Meridian Venture Partners II GP, L.P. |
13D/G
|
Robert E. Brown, Jr. |
4.8%
|
1,034,570
|
$66,419,394 | -$9,630,000 | 21 Aug 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.3%
|
727,204
|
$57,405,484 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13D/G
13F
|
Company |
3.8%
|
818,341
|
$57,136,569 | -$19,037,261 | 31 Mar 2025 | |
| Global Alpha Capital Management Ltd. |
13F
|
Company |
2.6%
|
590,135
|
$46,585,257 | — | 31 Dec 2025 | |
| Muthusamy Shanmugam |
3/4/5
|
HEAD OF R&D, COO-NOVITIUM OPS, Director |
2.4%
|
537,976
|
$44,650,672 | -$17,860,541 | 26 Feb 2026 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.2%
|
487,667
|
$38,497,108 | — | 31 Dec 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
2.2%
|
486,243
|
$38,384,022 | — | 31 Dec 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.2%
|
481,437
|
$38,004,637 | — | 31 Dec 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
2.1%
|
477,684
|
$37,708,375 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
477,272
|
$37,681,704 | — | 31 Dec 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
2.1%
|
473,207
|
$37,354,961 | — | 31 Dec 2025 | |
| Nikhil Lalwani |
3/4/5
|
PRESIDENT & CEO, Director |
1.8%
|
404,889
|
$32,905,329 | -$4,894,573 | 07 Mar 2026 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.8%
|
400,278
|
$31,597,946 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.8%
|
392,576
|
$30,989,950 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
1.7%
|
387,102
|
$30,557,832 | — | 31 Dec 2025 | |
| Ranger Investment Management, L.P. |
13F
|
Company |
1.6%
|
362,378
|
$28,606,119 | — | 31 Dec 2025 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
316,693
|
$24,999,745 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.4%
|
314,402
|
$24,818,894 | — | 31 Dec 2025 | |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. |
13F
|
Company |
1.3%
|
299,278
|
$23,625,000 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
281,427
|
$22,215,920 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.2%
|
269,903
|
$21,306,143 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.1%
|
253,536
|
$20,014,132 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.1%
|
251,629
|
$19,863,593 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.1%
|
244,670
|
$19,314,250 | — | 31 Dec 2025 | |
| Aberdeen Group plc |
13F
|
Company |
1.1%
|
240,792
|
$19,008,121 | — | 31 Dec 2025 | |
| Chad Gassert |
3/4/5
|
SVP - CORP. DEV. & STRATEGY |
1%
|
233,406
|
$18,904,923 | -$3,051,835 | 26 Feb 2026 | |
| NOMURA HOLDINGS INC |
13F
|
Company |
1%
|
223,935
|
$17,677,429 | — | 31 Dec 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.99%
|
221,298
|
$17,470,000 | — | 31 Dec 2025 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.98%
|
219,355
|
$17,315,884 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.98%
|
217,881
|
$17,199,526 | — | 31 Dec 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.96%
|
213,801
|
$16,877,451 | — | 31 Dec 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.92%
|
205,089
|
$16,189,726 | — | 31 Dec 2025 | |
| MIZUHO MARKETS AMERICAS LLC |
13F
|
Company |
0.91%
|
201,994
|
$15,945,406 | — | 31 Dec 2025 | |
| APIS CAPITAL ADVISORS, LLC |
13F
|
Company |
0.88%
|
196,000
|
$15,472,240 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.87%
|
193,573
|
$15,280,653 | — | 31 Dec 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.86%
|
192,006
|
$15,156,951 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.85%
|
189,836
|
$14,985,653 | — | 31 Dec 2025 | |
| OBERWEIS ASSET MANAGEMENT INC/ |
13F
|
Company |
0.85%
|
188,830
|
$14,906,240 | — | 31 Dec 2025 | |
| Stephen P. Carey |
3/4/5
|
SVP & CFO |
—
mixed-class rows
|
190,331
mixed-class rows
|
$14,660,539 | -$4,855,531 | 07 Mar 2026 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.81%
|
181,151
|
$14,300,060 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.79%
|
176,814
|
$13,957,698 | — | 31 Dec 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.77%
|
171,971
|
$13,575,390 | — | 31 Dec 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.76%
|
168,829
|
$13,327,362 | — | 31 Dec 2025 | |
| TEACHER RETIREMENT SYSTEM OF TEXAS |
13F
|
Company |
0.68%
|
151,275
|
$11,941,649 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.68%
|
150,779
|
$11,902,493 | — | 31 Dec 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.65%
|
145,000
|
$11,446,300 | — | 31 Dec 2025 | |
| Freestone Grove Partners LP |
13F
|
Company |
0.63%
|
141,109
|
$11,139,144 | — | 31 Dec 2025 |
Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock (ANIP) as of Q1 2026
As of 31 Mar 2026,
ANI PHARMACEUTICALS INC - Common Stock (ANIP) was held by
129 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,258,413 shares.
The largest 10 holders included
VANGUARD CAPITAL MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, UBS Group AG, Nuveen, LLC, VANGUARD PORTFOLIO MANAGEMENT LLC, Global Alpha Capital Management Ltd., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, Invesco Ltd., DEUTSCHE BANK AG\, and TEACHER RETIREMENT SYSTEM OF TEXAS.
This page lists
137
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
283
Q1 2026 holders
129
Holder diff
-154
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.